PDA drag panel
BUSINESS ANALYSIS DECADAL
: Daxor Corporation is engaged in the development and marketing of cryopreservation (freezing) technology for human semen and blood. For the three months ended 3/31/00, revenues fell 28% to $718K. Net income fell 70% to $94K. Revenues reflect a decrease in gains on sale of securities, offset by an increase in operating and other revenues. Net income reflect increased selling, general and administrative expenses.